AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06562933 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham vacuum
Description: Participants will undergo a total of 10 treatment sessions over two weeks, with one session per day, five days a week. Two-channel four vacuum electrodes will be placed on the neck so that the painful area remains in the middle. The vacuum electrodes will apply continuous vacuum mode for only 10 minutes without delivering interferential current. Following the sham vacuum therapy, a hot pack will be applied to the painful neck area for 20 minutes.
Study NCT06562933 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Interferential Current Therapy Vacuum Electrodes
Description: Participants will undergo a total of 10 treatment sessions over two weeks, with one session per day, five days a week. Two-channel four vacuum electrodes will be placed on the neck so that the painful area remains in the middle. Interferential current therapy with a 4000 Hz carrier frequency and 50 Hz amplitude-modulated frequency will be applied for 10 minutes using the vacuum electrodes. After the interferential current therapy, a hot pack will be applied to the painful neck area for 20 minutes.
Study NCT06562933 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Interferential Current Therapy Carbon-silicon Pad Electrodes
Description: Participants will undergo a total of 10 treatment sessions over two weeks, with one session per day, five days a week. Two-channel four carbon-silicon pad electrodes will be placed on the neck so that the painful area remains in the middle. Interferential current therapy with a 4000 Hz carrier frequency and 50 Hz amplitude-modulated frequency will be applied for 10 minutes using the carbon-silicon pad electrodes. Following the interferential current therapy, a hot pack will be applied to the painful neck area for 20 minutes.
Study NCT06536257 — intervention group
Intervention type: OTHER
Intervention: Predictive model
Description: Patient who have not had immunotherapy will have tumour tested using the predictive model. This determines whether patients are likely to respond, or not to respond to immunotherapy. Results of the predictive model will be compared with the actual response to immunotherapy when this has been completed.
Study NCT05749588 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G1: SHR-A1811
Description: G1: an anti-HER2 antibody-drug conjugate (ADC)
Study NCT05749588 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H1: TROP2 ADC
Description: H1: an Trophoblast cell-surface antigen 2 (TROP2) ADC
Study NCT05510986 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl group
Description: Dilute fentanyl hydrochloride injection (1ml:0.1mg) with 0.9% normal saline to 10μg/ml, 1μg/kg fentanyl is slowly injected intravenously 10 minutes before the end of the operation, and the administration speed is not less than 5 minutes.
Study NCT05510986 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxycodone Hydrochloride group
Description: Dilute Oxycodone Hydrochloride injection (1ml:10mg) with 0.9% normal saline to~1mg/ml, 0.1mg/kg Oxycodone Hydrochloride is slowly injected intravenously 10 minutes before the end of the operation, and the administration speed is not less than 5 minutes.
Study NCT05053854 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Talazoparib
Description: During dose escalation, doses of talazoparib that can be administered are 0.1mg, 0.25mg, 0.5mg or 1mg oral daily. Talazoparib will be given on days 2-6 of each cycle of 177Lu-DOTA-Octreotate for cycles 2-4, every 8 weeks
Study NCT05790824 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spa therapy
Description: The RH2 rheumatology treatment protocol will propose treatments that can be carried out with water from the SL5 borehole and will be composed of:~* 54 treatments among the following treatments:~  * Swimming pool, 15 minutes (code 201)~ * Bath with aerobath, 10 minutes (code 205)~ * Bath with immersion shower, 10 minutes (code 206)~ * Cataplasm in multiple local application, 10 minutes (code 408)~* 18 sessions of mobilization pool, 15 minutes (code 601)
Study NCT05674734 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 4FM Acceptance Training
Description: 4FM Acceptance Training, therapeutic intervention in the form of an additional to TAU module - 12 (1,5 hour) group meetings in the form of 4FM Acceptance Training at Day Care Units at IPIN Mental Health Centre for Mokotów and IPiN (1 meeting weekly).
Study NCT06225921 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: Adebrelimab will be given at a dose of 20 mg per kilogram of body weight every three weeks on day 23 of a planned 28-day cycle, and two doses before surgery.
Study NCT06225921 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dalpiciclib 100mg
Description: Dalpiciclib will be given at a dose of 100 mg every day orally with three weeks on and one week off. Four weeks is a cycle and it will be given for two cycles.
Study NCT06225921 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dalpiciclib 150mg
Description: Dalpiciclib will be given at a dose of 150 mg every day orally with three weeks on and one week off. Four weeks is a cycle and it will be given for two cycles.
Study NCT05520567 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Subcutaneous injection or intravenous infusion
Study NCT06302114 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Assessment of overhead athletes
Description: Assessment of medicine ball forward throw, Y balance test, Range of motion of the shoulder (internal and external rotation), strength of internal and external rotator muscles.
Study NCT04454229 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Direct oral penicillin challenge
Description: The patient will receive a single dose of oral penicillin, following baseline vital signs.
Study NCT04454229 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Routine management as per the treating clinicians that include skin prick and intradermal beta-lactam testing, followed by oral penicillin challenge in the setting of negative skin testing.
Study NCT04652856 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical Brain Stimulation
Description: Electrical Brain Stimulation (EBS) will be used to disrupt local neural activity in inferior temporal regions (ITC), parahippocampal cortex (PHC), the hippocampus, and control regions. The effects of EBS will be examined on attention and eye movement behavior, and all participants will receive both EBS and sham electrical brain stimulation.
Study NCT04652856 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham Electrical Brain Stimulation
Description: Sham electrical brain stimulation (SEBS) will be applied to inferior temporal regions (ITC), parahippocampal cortex (PHC), the hippocampus, and control regions. The effects of SEBS will be examined on attention and eye movement behavior, and all participants will receive both SEBS and EBS.
Study NCT06155721 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Cognitive Stimulation Program
Description: Intervention Type: Device Intervention Name: Virtual Reality Cognitive Stimulation Program Description: This program utilizes virtual reality to conduct cognitive stimulation exercises aimed at improving memory, executive functions, and attention in individuals with Mild Cognitive Impairment (MCI). It includes interactive tasks such as virtual shopping, payment simulations, and recipe sequencing, along with 360-degree video sessions for attention and episodic memory training.
Study NCT06558942 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: incisional negative pressure wound technology
Description: Negative pressure device used directly on closed or sutured incisions
Study NCT04603482 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resourcefulness Training
Description: A cognitive-behavioral intervention presented within an audiovisual format that consists of teaching and reinforcing personal (self-help) and social (help-seeking) resourcefulness skills.
Study NCT04603482 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Biofeedback Training
Description: Use of a heart-rate variability (HRV) tracking device to enable one to learn to alter physiology to improve health. Devices are used to measure physiological activity, e.g., breathing and heart function, and provide rapid, accurate feedback to the user, thereby enabling desired physiological changes that can endure over time without continued use of the device and to continue to influence behavior.
Study NCT04603482 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diversional Activites
Description: An audiovisual format presenting 12 activities for adults including but not limited; crossword puzzles, reading, gardening, exercise, cooking/baking, board games, learning a new language, social activities, online games, etc.
Study NCT06561724 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Biscuits maltodextrin
Description: Biscuits includes maltodextrin
Study NCT06561724 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Biscuits includes prebiotics tartoufa inulin
Description: Biscuits prebiotics
Study NCT06561724 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Biscuits includes prebiotics chicory inulin
Description: Biscuits prebiotics
Study NCT06081062 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fabagal® (Agalsidase beta)
Description: 1 mg/kg every 2 weeks for 12 months
Study NCT06081062 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Active comparator (Agalsidase beta)
Description: 1 mg/kg every 2 weeks for 12 months
Study NCT05600907 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: JSP191
Description: A monoclonal antibody that targets human CD117
Study NCT06459258 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motion-triggered NMES training protocol
Description: Experimental group subjects undergo a motion-triggered NMES shoulder strengthening training program (3x/week, 30 minutes for 6 weeks) using the Shoulder Pacemaker (NCS Lab Srl, Modena, Italy), a motion activated stimulation device to strengthen muscular disbalances. This is accomplished through varying neuromuscular electrical stimulation intensity based on the angle of motion of the arm producing subtetanic contraction and provoking supraspinal neural adaptations. Electrode placement: electrode 1, inferior to the scapular spine (infraspinatus, teres minor, + posterior deltoid); electrode 2, medial to the medial scapula border (lower trapezius + rhomboids) . Sets x repetitions: 3x20 Levels: Level 1-3; Exercise 1: L1: Supported row, L2: Front raises in 45°, L3 Front raises (thumbs up) Exercise 2: L1: Resisted front raises, L2: Crossbody resisted raises, L3: Crossbody; forehand swing; Exercise 3: L1: Rear dealt fly, L2: Single arm resisted row, L3: Underhand volleyball
Study NCT06459258 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non-Motion-triggered NMES training protocol
Description: Arm Description: Subjects of the control group undergo a conventional standardized strength training program (3x/week, 30 minutes for 6 weeks) with concentric, eccentric, and functional training exercises.
Study NCT06318117 — intervention group
Intervention type: OTHER
Intervention: Rice infant formula
Description: Any commercially available rice infant formula whom the pediatrician has previously deemed, or is deeming it useful to consume.
Study NCT04874454 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ultrasound
Description: evaluate the vocal cord movement among the stroke patients
Study NCT06166823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EMR alert
Description: EMR alert for medication optimization
Study NCT06273904 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active transcranial focused ultrasound (tFUS)
Description: Active non-invasive low-intensity focused ultrasound will be delivered using a proprietary head-worn device and control software from Attune Neurosciences. On an active stimulation day, focused ultrasound will be delivered to the brain region of interest using parameters from published research that are demonstrated to safely cause temporary changes in the activity in that brain area.
Study NCT06273904 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham transcranial focused ultrasound (tFUS)
Description: Non-active low-intensity ultrasound will also be conducted using a proprietary head-worn device and control software from Attune Neurosciences. On the sham stimulation day, the device will be activated in a manner that produces similar sensory effects (i.e., low-volume beeping-type noise from the device) but also prevents delivery of a focused ultrasound beam to the brain area of interest or any other brain area.
Study NCT04685148 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Transdermal patch estradiol
Description: Estradiol patches (200 μg per day by transdermal delivery) will be administered at day 0 (+1) to day 21 postpartum.
Study NCT04685148 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Transdermal patch placebo
Description: Placebo patches will be administered at day 0 (+1) to day 21 postpartum.
Study NCT05981950 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: artificial intelligence algorithm
Description: Retinal diseases diagnosed by artificial intelligence algorithm
Study NCT06568367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Solriamfetol 150 mg
Description: Solriamfetol tablets, taken once daily
Study NCT06568367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Solriamfetol 300 mg
Description: Solriamfetol tablets, taken once daily
Study NCT06568367 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets, taken once daily
Study NCT05587296 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elinzanetant (BAY3427080)
Description: 120 mg elinzanetant orally once daily
Study NCT05587296 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Elinzanetant (BAY3427080)
Description: 120 mg elinzanetant orally once daily
Study NCT05587296 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo orally once daily
Study NCT06594926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone Enanthate
Description: Testosterone enanthate is a depot formulation used in Australia typically for androgen replacement in people with confirmed testosterone deficiency.
Study NCT05647005 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Classical music
Description: A total of 15 sessions of music will be applied to this group, two or three days a week, on different days, 3 sessions a day. Sessions will be in the form of listening to classical music for 30 minutes after the babies are fed.
Study NCT05647005 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Harp music
Description: A total of 15 sessions of music will be applied to this group, two or three days a week, on different days, 3 sessions a day. Sessions will be in the form of listening to harp music for 30 minutes after the babies are fed.
Study NCT06616532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PM8002
Description: Following a predefined dose and date.
Study NCT06616532 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: 175mg/m2 via IV infusion on Day 1 Q3W
Study NCT06616532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: 175mg/m2 via IV infusion on Day 1 Q3W
Study NCT06616532 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topotecan
Description: 1.25mg/m2/day via IV infusion on Days 1-5 Q3W
Study NCT06669338 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music therapy
Description: patients listen to music for 20 minutes with headphones before colonoscopy.
Study NCT06669338 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: listen to white noise
Description: patients listen to white noise with headphones for 20 minutes before colonoscopy.
Study NCT06669338 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: listen to hospital ambient sound
Description: patients listen to recorded ambient sound for 20 minutes with headphones before colonoscopy.
Study NCT06356805 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation
Description: Parallel study: Participants are assigned to one of two groups in parallel for 3 months follow up
Study NCT06356805 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation
Description: Parallel study: Participants are assigned to one of two groups in parallel for 3 months follow up
Study NCT05460208 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Enriched spread
Description: The experimental spread is made with a base made with 90% extra virgin olive oil to which plant sterols are added.
Study NCT05460208 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control spread
Description: The control spread will be the same base spread made with extra virgin olive oil without the added plant sterols.
Study NCT06266637 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physical Therapy Program
Description: Conventional Physical Therapy program:~trunk muscles strengthening exercises, trunk muscles endurance exercises, trunk proprioception exercises . postural correction exercises. Core exercise Spinal mobility exercises
Study NCT06266637 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physical Therapy Program
Description: Conventional Physical Therapy program:~trunk muscles strengthening exercises, trunk muscles endurance exercises, trunk proprioception exercises . postural correction exercises. Core exercise Spinal mobility exercises
Study NCT06266637 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapeutic Scoliosis-Specific Exercise (Schroth)
Description: It uses exercises customized for each patient to return the curved spine to a more natural position. The spine is addressed in all three anatomical planes - sagittal, frontal and transverse. The purpose of the method is to create spinal balance and stability by improving body mechanics and spinal stabilization to prevent further curve progression
Study NCT05653908 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: StudentMood
Description: StudentMood is an app that uses ecological momentary assessment method to asses mood and other mental health corelates. Participants will have to complete the application (the mood wheel, heart rate and other behavioral data as well as standardized scales) daily throughout the entire semester
Study NCT06523790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga
Description: Participants in the yoga group will attend 90-minute yoga sessions, 3 times per week, for 8 months. The sessions will include a combination of asanas (postures), pranayama (breathing exercises), and meditation.
Study NCT06523790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brisk walking
Description: Participants in the brisk walking group will engage in one-hour fast-paced walking sessions, 6 times per week, for 8 months. The walking regimen is designed to improve cardiovascular fitness, endurance, and support weight loss.
Study NCT05872399 — intervention group
Intervention type: OTHER
Intervention: Attitudes Towards Psychiatry - 30
Description: The participants will answer their beliefs in 30 statements about psychiatry and mental health.
Study NCT05159193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pegylated liposomal doxorubicin (PLD)
Description: pegylated liposomal doxorubicin (PLD) 30 mg/m\^2, i.v., d1, q3w
Study NCT05478746 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BioNourish, a component of the Flourish HEC kit
Description: BioNourish is a vaginal moisturizing gel which obtained FDA 510k clearance in 2020. It is one component of the full system being tested. The main intervention is to use this kit to improve the vaginal microbiome.
Study NCT05478746 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control - no intervention
Description: No intervention; participants only receive routine care.
Study NCT05159193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide (C)
Description: cyclophosphamide (C) 600 mg/m\^2, i.v., d1, q3w
Study NCT05159193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: trastuzumab (H)
Description: trastuzumab (H) 8 mg/kg loading dose, 6 mg/kg maintenance doses, i.v., d1, q3w
Study NCT05159193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pertuzumab (P)
Description: pertuzumab (P) 840 mg loading dose, 420 mg maintenance doses, i.v., d1, q3w
Study NCT05414773 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: measurement of axial length and keratometry by sonographers with a topographic module
Description: measurement of axial length and keratometry by sonographers with a topographic module
Study NCT06274021 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous spinal stimulation at 100 Hz
Description: Transcutaneous spinal stimulation (TSS) is a non-invasive neuromodulation method that uses electrical currents to stimulate sensory fibers. The procedure involves placing surface electrodes midline on the lower back (T11-12 spinal processes) and on each side of the belly button. The stimulation frequency during the intervention is 100 Hz, performed at a sub-motor threshold for 30 minutes.
Study NCT05159193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: docetaxel (T)
Description: docetaxel (T) 90\~100 mg/m\^2, i.v., d1, q3w